EV Biologics Corp., a Wyoming-based biotechnology company, has engaged Foley to facilitate the propriety development of its exosome technology and technical innovation.
In its announcement, the company cited Foley’s standing at the top of intellectual property law in biotechnology and organics and its specialty in stem cell and extracellular vesicle technology.
Exosomes are nano-sized vesicles that serve as mediators for cell-to-cell communication. The intrinsic properties of exosomes in regulating complex intracellular pathways has advanced their potential utility in the therapeutic control of many diseases, including neurodegenerative conditions and cancer.
Related News
October 21, 2026
Press Releases
Foley Expands New York Platform with Addition of Two Partners
Foley & Lardner LLP announced today that partners Marisa White and Rena Andoh have joined its New York office, continuing the firm’s strategic growth in the market. White joins the Transactions Practice Group, while Andoh joins the Commercial Litigation Practice Group.
October 19, 2026
Press Releases
Foley Welcomes 2026 New Associate Class
Foley & Lardner LLP is proud to welcome its 2026 new associate class, a group of 64 recent law school graduates and judicial clerks. Representing 18 offices and 17 practice areas across the firm, the new class underscores Foley's firmwide investment in cultivating the next generation of legal talent.
October 9, 2026
Press Releases
Foley Releases 2026 State AG Election Report and Interactive Map on Key Races and Enforcement Trends
Foley & Lardner LLP released today its 2026 State Attorneys General Election Report, a special report examining why the upcoming attorneys general (AG) races matter and how this election cycle may affect the state enforcement, regulatory, and litigation landscape for businesses across the country. In light of the 33 attorneys general elections (30 states, Washington, D.C., Guam, and the Northern Mariana Islands) in November 2026 there will be, at a minimum, 11 new attorneys general in January 2027.